Sources
Loading...
Additional media
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Fertility startups GametoGen and Natural Cycles have secured significant funding. GametoGen raised $33 million for a Phase 3 study using iPSC-derived granulosa cells for IVF. Natural Cycles, a contraceptive app, raised $55 million in a Series C round, eyeing an IPO soon.
Natural Cycles, an FDA-cleared birth control app with ~3M users, raised a $55M Series C led by Lauxera Capital Partners, bringing its total funding to $95M+ (@cate_lawrence / https://t.co/5BsBJf8Atd) https://t.co/The07WxSaw https://t.co/9JGznWSwie
A biotech working on a new approach to IVF raises $33M in fresh funding https://t.co/etINwldMiP by @Lilah_Alvarado
Profitable for two years, @NaturalCycles has just raised a $55M Series C. "In two to three years, we'll be in the IPO zone" says physicist co-founder Elina Berglund. Story via @Cate_Lawrence on https://t.co/cMkS4KTF2U: https://t.co/Yt8F6M0iT8 https://t.co/eJjCmyVvkx